James L. Tyree, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 10,096 shares at $52.91 ($535K) on 2008-03-04, disclosed to the SEC on 2008-03-06.
Open-market sale of $535k ABT by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.90 | 384 | $20K | 3.8% |
| 2 | $52.91 | 300 | $16K | 3.0% |
| 3 | $52.92 | 200 | $11K | 2.0% |
| 4 | $53.04 | 5,307 | $281K | 52.6% |
| 5 | $53.05 | 900 | $48K | 8.9% |
| 6 | $53.06 | 500 |
| $27K |
| 5.0% |
| 7 | $53.07 | 700 | $37K | 6.9% |
| 8 | $53.08 | 1,805 | $96K | 17.9% |
| Total | $53.04 avg | 10,096 | $535K | 100% |
| Filing → |
| ASRT | SELL | 2024-03-15 | $11K | — | Filing → |
| GNLX | SELL | 2023-12-14 | $192K | — | Filing → |
| ASRT | SELL | 2023-05-05 | $259K | — | Filing → |